DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2006; 131(39): 2165-2168DOI: 10.1055/s-2006-951348 Übersicht | Review articleKardiologie© Georg Thieme Verlag KG Stuttgart · New YorkICD-Implantation - Bei welchen Patienten ist ihr Wert in der Primärprophylaxe gesichert?ICD-implantation - When is primary prevention evidence based?M. Fiek1 , C. Reithmann1 , G. Steinbeck1 1Medizinische Klinik I, Klinikum der Universität München - Großhadern Recommend Article Abstract Buy Article Schlüsselwörter ICD-Implantation - Primärprophylaxe - Indikation Key words defibrillator implantation - primary prevention - indications Full Text References Literatur 1 Bänsch D, Antz M, Boczor S. et al . Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial (CAT). Circulation. 2002; 105 1453-1458 2 Bardy G H, Lee K L, Mark D B. et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352 225-237 3 Bigger J T. for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 1997; 337 1569-1575 4 Bloomfield D M, Bigger J T, Steinman R C. et al . Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol. 2006; 47 456-463 5 Bloomfield D M, Steinman R C, Namerow P B. et al . Microvolt T-Wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II. Circulation. 2004; 110 1885-1889 6 Bristow M R, Saxon L A, Boehmer J. et al. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators . Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350 2140-2150 7 Buxton A E, Lee K L, Fisher J D. et al., for the Multicenter Unsustained Tachycardia Trial Investigators . A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999; 341 1882-1890 8 Cleland J GF, Daubert J C, Erdmann E. et al . The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352 1539-1549 9 Cohn J N, Bristow M R, Chien K R. et al . Report of the national Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation. 1997; 95 766-770 10 Connolly S J, Gent M, Roberts R S. et al. for the CIDS investigators . Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter against amiodarone. Circulation. 2000; 101 1297-1302 11 Gregoratos G. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation). www.acc.org/clinical/guidelines/pacemaker 12 Hohnloser S H, Kuck K H, Dorian P. et al . Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004; 351 2481-2488 13 Kadish A. Prophylactic defibrillator implantation - toward an evidence-based approach. N Engl J Med. 2005; 352 285-287 14 Kadish A, Dyer A, Daubert J P. et al. for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators . Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004; 350 2151-2158 15 Kuck K H, Cappato R, Siebels J. et al . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 101 7481-7454 16 Moss A J. Should everyone with an ejection fraction less than or equal to 30 % receive an implantable cardioverter-defibrillator?. Circulation. 2005; 111 2735-2749 17 Moss A J, Brown M W, Cannom D S. et al . Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005; 10 34-43 18 Moss A J, Daubert J, Zareba W. MADIT-II: Clinical Implications. Card Electrophysiol Rev. 2002; 6 463-465 19 Moss A J, Hall W J, Cannom D S. et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators . Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996; 335 1933-1940 20 Moss A J, Zareba W, Hall W J. et al., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346 877-883 21 Myerburg R J. Sudden cardiac death:exploring the limits of our knowledge. J Cardiovasc Electrophysiol. 2001; 12 369-381 22 Myerburg R J, Castellanos A. Spend in the beginning or pay at the end. J Am Coll Cardiol. 2006; 47 108-111 23 Olshansky B, Poole J E, Johnson G W. et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators .Syncope predicts the outcome of cardiomyopathy patients - analysis of the SCD-HeFT Trial. AHA Scientific Sessions 2005 24 Sharma A, Poole J E, Anderson J. et al. for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators .Mortality in non-ischemic dilated cardiomyopathy with LVEF >35 % during follow up in the Sudden Cardiac Death in Heart Failure trial. AHA Scientific Sessions 2005 25 Strickberger S A, Hummel J D, Bartlett T G. et al . Amiodarone Versus Implantable Cardioverter-Defibrillator: Randomized Trial in Patients With Nonischemic Dilated Cardiomyopathy and Asymptomatic Nonsustained Ventricular Tachycardia - AMIOVIRT. J Am Coll Cardiol. 2003; 41 1707-1712 26 The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators . A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients rescuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337 1576-1583 27 Vyas A, Moss A J, Zareba W. et al . Risk stratification of MADIT-II patients for predicting mortality and ICD benefit. Circulation. 2004; 110 III-503 Dr. Michael Fiek Medizinische Klinik und Poliklinik I, Klinikum der Universität München - Großhadern Marchioninistraße 15 81377 München Phone: +49/89/70952235 Fax: +49/89/70958830 Email: Michael.Fiek@med.uni-muenchen.de
